HIV 1 News and Research

RSS
COVID-19 pandemic could increase the global burden of tuberculosis

COVID-19 pandemic could increase the global burden of tuberculosis

Sex in the time of COVID: Gay men begin to embrace a ‘new normal’

Sex in the time of COVID: Gay men begin to embrace a ‘new normal’

Discovery provides a potential target for infectious diseases immunotherapy

Discovery provides a potential target for infectious diseases immunotherapy

Chemist develops new drug to treat type 2 diabetes without undesired side effects

Chemist develops new drug to treat type 2 diabetes without undesired side effects

First clinical trial in South Africa for Covid-19 vaccine begins

First clinical trial in South Africa for Covid-19 vaccine begins

ILC Therapeutics announces research partnership with University of St Andrews to fight against COVID-19

ILC Therapeutics announces research partnership with University of St Andrews to fight against COVID-19

Single-dose Israeli vaccine candidate protective against SARS-CoV-2

Single-dose Israeli vaccine candidate protective against SARS-CoV-2

UTHealth tests arthritis drug's effect on COVID-19-induced cytokine storm

UTHealth tests arthritis drug's effect on COVID-19-induced cytokine storm

The role of brain cells in spreading HIV

The role of brain cells in spreading HIV

Indonesians prefer to seek initial TB care at private clinics

Indonesians prefer to seek initial TB care at private clinics

New adjuvant helps induce long-lasting immunity against HIV

New adjuvant helps induce long-lasting immunity against HIV

Researchers find prothrombotic antibodies in patients with COVID-19

Researchers find prothrombotic antibodies in patients with COVID-19

Researchers use aquaculture to tackle snail fever

Researchers use aquaculture to tackle snail fever

Globally, 350 million could be at risk of severe COVID-19 and hospitalization

Globally, 350 million could be at risk of severe COVID-19 and hospitalization

A new system for detecting antibodies within minutes

A new system for detecting antibodies within minutes

Nanosponges could attack and neutralize SARS-COV-2 virus

Nanosponges could attack and neutralize SARS-COV-2 virus

Researchers take actions to reduce hospitalizations and deaths from COVID-19

Researchers take actions to reduce hospitalizations and deaths from COVID-19

Mapping RNA sequences of therapeutic value in the SARS-CoV-2 genome

Mapping RNA sequences of therapeutic value in the SARS-CoV-2 genome

Antibiotic X-206 effective against SARS-CoV-2 in vitro

Antibiotic X-206 effective against SARS-CoV-2 in vitro

Hepatitis C virus co-opts an immune protein to evade antiviral defenses

Hepatitis C virus co-opts an immune protein to evade antiviral defenses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.